Concepedia

Performance of plasma phosphorylated tau 181 and 217 in the community

Michelle M. Mielke, Jeffrey L. Dage, Ryan D. Frank, Alicia Algeciras‐Schimnich, David S. Knopman, Val J. Lowe, Guojun Bu, Prashanthi Vemuri, Jonathan Graff‐Radford, Clifford R. Jack,

Nature Medicine · 2022 · 491 citations · 28 references

DOIFull text

Open access

Concepts

References

28

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

Mary E. Charlson, Peter Pompei, Kathy L. Aleš et al. · Journal of Chronic Diseases · 1987 · 49.9K citations

, , +15

Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders

Sebastian Palmqvist, Shorena Janelidze, Yakeel T. Quiroz et al. · JAMA · 2020 · 1.5K citations · Full text

, , +13

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

Thomas K. Karikari, Tharick A. Pascoal, Nicholas J. Ashton et al. · The Lancet Neurology · 2020 · 1.4K citations · Full text

, , +16

Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia

Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist et al. · Nature Medicine · 2020 · 1.3K citations

, , +17

Blood-based biomarkers for Alzheimer's disease: towards clinical implementation

The Lancet Neurology · 2021 · 972 citations · Full text

, , +14